PHILADELPHIA and LONDON, June 23, 2015 /PRNewswire/ -- L2FU® (Lost to Follow Up), a global leader specializing in locating clinical trial patients lost to follow up, has just released its newly published guide; "Maintaining Clinical Trial Integrity & Minimizing Missing Data: The Official Guide To Lost To Follow Up Management." The booklet is a resource for study sponsors, research centers and hospitals.
The 24-page guide features tips for securing accurate patient contact info and staying on top of changes; identifying at-risk patients promptly by noting such red flags as missing a visit, lacking reliable transportation or experiencing employment or financial problems; and locating lost to follow up patients via a proven five-step process. The booklet also features unique insights from the L2FU team based on their years of experience and 90 percent success rate locating patients lost to follow up. In addition to covering proven methods for lost to follow up patient management, the guide also includes background on L2FU's experience optimizing clinical trials by reducing the number of patients lost to follow up—and the important data they represent.
"This best practice guide reflects more than a decade of experience and hard work," says Hema Gadhia, Senior Operations Support Manager at L2FU. "We hope others can benefit from what we've learned locating patients in more than 60 countries. The booklet includes an overview on the impact of patients lost to follow up and detailed steps for locating those patients quickly. It is five times more costly to recruit a new patient than it is to retain one, so these guidelines can truly help sponsors save money, meet timelines and maintain data integrity."
To request your free copy, visit L2FU.net today and click "download the booklet" at the top of the page.
L2FU, an affiliate of MediciGroup® Inc. is dedicated to finding patients for clinical trials. Working within strict privacy guidelines in more than 60 countries, the L2FU team proactively works with study sponsors, clinical sites and hospitals to swiftly recover patients and, consequently, potential missing data. Minimizing the number of lost patients in a study requires proactive development and implementation of programs that keep patients interested and coming back for study visits.
The L2FU team has years of experience in proactively recovering lost study subjects. It has access to many databases containing millions of vital records. As shown by the Tufts University Center for Drug Development, study coordinator workload has increased significantly. Thus, the services provided by the L2FU team are valued by sponsors, clinical research organizations (CROs) and research centers alike. Study sponsors retain L2FU services so that study coordinators can focus their time on patients still active in the study. L2FU's success in recovering lost patients ensures critical study data is accounted for.
For press inquiries please contact:
U.S. media contacts:
Bernard Hall: +1-484-674-6816
Outside the U.S., media contact:
Elizabeth Puller +44 (0)208 834 1447